Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Dialysis world news


More Hospitalizations, Higher Charges, for Kids With High Blood ... - MarketWatch (press release)

Study Highlights: , Jun 18, 2012 (GlobeNewswire via COMTEX) -- During 10 years ending in 2006, hospitalizations for children with high blood pressure increased dramatically. -- Related hospital charges to treat them also soared. -- Researchers suggest healthcare providers address healthy lifestyle habits during children's well visits to reduce risk of hypertension.

EMBARGOED UNTIL 3 pm CT/4 pm ET, Monday, June 18, 2012

DALLAS, June 18, 2012 (GLOBE NEWSWIRE) -- Hospitalizations for children with high blood pressure and related charges dramatically increased during 10 years ending in 2006, according to a study published in the American Heart Association journal Hypertension.

This nationally-based study is the first in which researchers examined hypertension hospitalizations in children.

While researchers expected a rise in hospitalizations due to the increased frequency of high blood pressure in children, "the economic burden created by inpatient childhood high blood pressure was surprising," said Cheryl Tran, M.D., study lead author and pediatric nephrology fellow in the Department of Pediatric Nephrology at the University of Michigan in Ann Arbor.

Researchers obtained discharge records from the Healthcare Cost and Utilization Project (HCUP) Kids' Inpatient Database from 1997, 2000, 2003 and 2006.

They found:




        
          --  Pediatric hypertension-related hospitalizations in the United States
              nearly doubled, from 12,661 in 1997 to 24,602 in 2006.
          --  Charges for inpatient care for hypertensive children increased by 50
              percent, reaching an estimated $3.1 billion. That does not include
              outpatient charges, a figure that remains unknown nationwide.
          --  The most significant increases in healthcare charges were for children
              with hypertension and end stage kidney disease.
          --  Average length of stay for children with hypertension was double that of
              children with other illnesses, eight days compared to four days.
        
        
        



Researchers hypothesize that the increasing hospitalizations may in part be due to the rise in childhood obesity.

Children hospitalized with hypertension were more likely to be older than 9 years, male, African-American and treated in a teaching hospital.

Overall, the most common diagnoses for hospitalized children were pneumonia, acute appendicitis and asthma. When hypertension was the primary diagnosis, convulsive disorder, headache, obesity and systemic lupus erythematosus were the most common secondary diagnoses.

When high blood pressure was in any diagnoses, the most common primary diagnoses were lupus, complications of kidney transplant, pneumonia and acute proliferative glomerulonephritis, a condition in the kidney that causes inflammation that can result in hypertension.

Physicians should address healthy lifestyle habits during children's well visits to reduce hypertension, Tran said.

"A child with high blood pressure is at increased risk for having high blood pressure in adulthood and the heart and stroke risks that come with that diagnosis," she said.

Hypertension is present in 1 percent to 3 percent of children in the United States.

Among children ages 2 to 19 years, 31.7 percent are overweight (23.6 million) and 16.9 percent are obese (12.6 million), according to American Heart Association statistics.

Co-authors are Brett J. Ehrmann, B.A.; Kassandra L. Messer, B.A.; Emily Herreshoff, B.A.; Amber Kroeker, M.P.H.; Larysa Wickman, M.D.; Peter Song, Ph.D.; Nicole Kasper, M.P.H. and Debbie S. Gipson, M.D. Author disclosures are on the manuscript.

A research training grant in pediatric nephrology funded the study.

Learn more about high blood pressure in children. Learn more about preventing and managing childhood obesity and reducing sodium in the diets of American children.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding .

NR12-- 1085 (Hypertension/Tran)

The American Heart Association logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9940

Additional resources available on the right column of this link:

http://newsroom.heart.org/pr/aha/_prv-more-hospitalizations-higher-charges-235126.aspx

For Media inquiries: (214) 706-1173

Karen Astle: (214) 706-1392; This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Bridgette McNeill: (214) 706-1135; This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Julie Del Barto (broadcast): (214) 706-1330; This e-mail address is being protected from spambots. You need JavaScript enabled to view it

For Public Inquiries: (800) AHA-USA1 (242-8721)

This news release was distributed by GlobeNewswire, www.globenewswire.com

SOURCE: American Heart Association

http://www.heart.org and http://www.strokeassociation.org

(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.

...

 
Research and Markets: Brazil Nephrology and Urology Devices ... - Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rp6xfk/brazil_nephrology) has announced the addition of GlobalData's new report "Brazil Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“Brazil Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

GlobalData's new report, Brazil Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters provides key market data on the Brazil Nephrology and Urology Devices market.

The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories:

- Incontinence Devices

- Lithotripters

- Renal Dialysis Equipment

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the Brazil Nephrology and Urology Devices market.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Brazil Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- B. Braun Melsungen AG

- Baxter International Inc.

- C. R. Bard, Inc.

- Coloplast A/S

- Covidien plc

- Dornier MedTech GmbH

- First Quality Enterprises, Inc.

- Fresenius Medical Care AG & Co. KGaA

- Gambro AB

- Hypermarcas SA

- Kimberly-Clark Corporation

- Medline Industries, Inc.

- Nipro Corporation

- Pro Descart Industria e Comercio Ltda

- Storz Medical Ag

- Siemens Healthcare

- Svenska Cellulosa Aktiebolaget SCA

- Teleflex Incorporated

For more information visit http://www.researchandmarkets.com/research/rp6xfk/brazil_nephrology

Source: GlobalData

...

 
Research and Markets: India Nephrology and Urology Devices Market Outlook ... - Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a) has announced the addition of GlobalData's new report "India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

This new report provides key market data on the India Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the India Nephrology and Urology Devicesmarket.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, First Quality Enterprises, Inc., Kimberly-Clark Corporation, Allengers Medical Systems Ltd. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Svenska Cellulosa Aktiebolaget Sca

- Baxter International Inc.

- Fresenius Medical Care Ag & Co. Kgaa

- First Quality Enterprises, Inc.

- Kimberly-Clark Corporation

- Allengers Medical Systems Ltd.

- Dornier Medtech Gmbh

- Nipro Corporation

- Nikkiso Co., Ltd.

- Hartmann Group

- Siemens Healthcare

- Coloplast A/S

- Covidien Plc

- B. Braun Melsungen Ag

- Gambro Ab

- C. R. Bard, Inc

- Direxgroup

- Ontex International N.V.

For more information visithttp://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a

Source: GlobalData

...

 
Research and Markets: India Nephrology and Urology Devices ... - Business Wire (press release)

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a) has announced the addition of GlobalData's new report "India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters" to their offering.

“India Nephrology and Urology Devices Market Outlook to 2018 - Incontinence Devices, Renal Dialysis Equipment and Lithotripters”

This new report provides key market data on the India Nephrology and Urology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within three market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope:

- Market size and company share data for Nephrology and Urology Devices market categories - Incontinence Devices, Lithotripters and Renal Dialysis Equipment.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within three market categories. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the three market categories.

- Global corporate-level profiles of key companies operating within the India Nephrology and Urology Devicesmarket.

- Key players covered include Svenska Cellulosa Aktiebolaget SCA, Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, First Quality Enterprises, Inc., Kimberly-Clark Corporation, Allengers Medical Systems Ltd. and others.

Reasons to Buy:

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the India Nephrology and Urology Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned:

- Svenska Cellulosa Aktiebolaget Sca

- Baxter International Inc.

- Fresenius Medical Care Ag & Co. Kgaa

- First Quality Enterprises, Inc.

- Kimberly-Clark Corporation

- Allengers Medical Systems Ltd.

- Dornier Medtech Gmbh

- Nipro Corporation

- Nikkiso Co., Ltd.

- Hartmann Group

- Siemens Healthcare

- Coloplast A/S

- Covidien Plc

- B. Braun Melsungen Ag

- Gambro Ab

- C. R. Bard, Inc

- Direxgroup

- Ontex International N.V.

For more information visithttp://www.researchandmarkets.com/research/p6g2z4/india_nephrology_a

Source: GlobalData

...

 
Foot Problems Boost Mortality in Diabetic Dialysis Patients - Renal Business Today

PHILADELPHIA—Diabetic patients on dialysis who have foot ulcers or who have undergone a foot amputation have a much higher mortality rate at two years than diabetic patients on dialysis without these pathologies, British investigators reported at the 72nd Scientific Sessions of the American Diabetes Association.

Agbor Ndip, MD, specialist registrar and senior clinical fellow at the Manchester Royal Infirmary, and colleagues examined the impact of foot ulcers and amputations on mortality in 192 diabetic patients undergoing dialysis a their institution.

Study participants underwent comprehensive foot examination at enrollment to assess for neuropathy, peripheral arterial disease, foot deformities, and foot ulcers/amputation.

Overall, 102 patients, or 53.1 percent, had died after two years. Thirty-five (59.3%) of 59 patients who had a foot ulcer at baseline had died after two years compared with 55 (41.4%) of 133 patients who did not have a foot ulcer at baseline. Additionally, 26 (74.3%) of 35 patients who had a foot amputation at baseline were dead at two years versus 64 (40.8%) of 157 patients without amputation at baseline. The differences in two-year mortality rates between patients with and without foot pathology were statistically significant.

Foot disease was a strong predictor of mortality on multivariate analysis that controlled for the type and duration of diabetes, age, gender, and patient history of retinopathy, ischemic heart disease, congestive heart failure, cerebrovascular disease, amputation, foot ulcer, peripheral vascular disease, and neuropathy, an active foot ulcer, or poor baseline glycemic control.

...

 
<< Start < Prev 301 302 303 304 305 306 307 308 309 310 Next > End >>

Page 308 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.